Clinical trial
Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies
NCT02517281 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies
- Lead sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 12, 2011
- Completion date
- June 22, 2022
- Enrollment
- 141 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer